Skip to main content
Clinical Trials/NCT04579419
NCT04579419
Completed
Phase 3

Injection Site Pain, Onset and Duration of Action of Botulinum Toxin Reconstituted in Normal Saline With and Without Sodium Bicarbonate; A Prospective, Single Center, Randomized, Double-Blind Interventional Study

King Abdulaziz Medical City1 site in 1 country30 target enrollmentNovember 9, 2019

Overview

Phase
Phase 3
Intervention
Sodium Bicarbonate
Conditions
Wrinkle
Sponsor
King Abdulaziz Medical City
Enrollment
30
Locations
1
Primary Endpoint
Injection site pain
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study was designed to investigate the effects of botulinum toxin type A injections diluted with the mixture of sodium bicarbonate (SB) and normal saline (NS) on pain reduction, onset of action and duration of action.

This is a prospective, randomized, double-blind clinical study, which included 30 female patients (age>25). The patients were randomized to receive botulinum toxin (BT) injections diluted with NS and SB on one side of the face and saline control injections on the other side. Pain severity was assessed using visual analogue scale. The onset and duration of action were recorded according to the patients' subjective opinions after 1 week and 3 months, respectively. The study was approved with an IRB (Institutional Review Board) number of RC19/371.

Registry
clinicaltrials.gov
Start Date
November 9, 2019
End Date
August 9, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Leen Hijazi

Medical Intern

King Abdulaziz Medical City

Eligibility Criteria

Inclusion Criteria

  • Any female patient who is in good health and has moderate dynamic forehead and glabellar wrinkles.

Exclusion Criteria

  • • Patients \<25 years old
  • Presence of neuromuscular disease or intake of drugs affecting muscle tone.
  • Any active infection in the treatment area.
  • Patients receiving anticoagulation or had a diagnosis of bleeding disorders.
  • Any patient who had undergone the following treatments to the forehead area in the past 6 months: botulinum toxin injections, ablative laser procedures, radiofrequency device treatments, ultrasound device treatments, or medium to deep chemical peels.
  • Any patient who had temporary soft-tissue augmentation material to the forehead area in the past 12 months, semi permanent soft-tissue augmentation material in the past 2 years, or permanent soft-tissue augmentation material at any point in the past.
  • Any patient with prior facial cosmetic surgical procedures such as eyebrow-lifts, blepharoplasties, and rhytidectomies.

Arms & Interventions

Sodium Bicarbonate

Intervention: Sodium Bicarbonate

Normal Saline

Intervention: Normal Saline

Outcomes

Primary Outcomes

Injection site pain

Time Frame: Immediately after the injections

Pain severity was assessed using Visual Analogue Scale (VAS).The VAS score ranged from 0 to 10, with 0 representing no pain and 10 the greatest imaginable pain. Higher scores indicated worse outcome.

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
Botulinum toxin type A injections in stiff knee gait.In the Netherlands live about 18.000 Cerebro Vascular Accident (CVA)-patients which discover problems with walking caused by insufficient footclearance. Causes of problems with the footclearance during the swing phase of gait are a combination of diminished dorsal flexion of the ankle, knee flexion and hip flexion. A diminished knee flexion during swing is defined a stiff knee gait. A stiff knee gait is often caused by an overactivity of the m. rectus femoris. Keywords: stroke, stiff knee gait
NL-OMON29171Roessingh Research and DevelopmentRoessinghsbleekweg 337577 AH Enschede26
Completed
Not Applicable
Effect of botulinum toxin A injections and specific intensive rehabilitation therapy in children with hemiparetic cerebral palsy on upper limb functions and skills
ISRCTN69541857Ipsen Biopharm Ltd (UK)60
Active, not recruiting
Phase 1
Evaluation of botulinum toxin injection efficacy in the treatment of head essential tremorTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2015-000162-59-FRCHU Clermont-Ferrand120
Recruiting
Not Applicable
Effects of Botulinum Toxin Injection Combined with RESWT in Lower Extremity Spasticity in Children with Cerebral PalsyCerebral Palsy, Spastic
NCT06494618Istanbul Medeniyet University20
Recruiting
Not Applicable
Assessment of Botulinum Toxin Injection for Treatment of Temporomandibular Joint DislocationDislocation of Temporomandibular Joint TMJSubluxation of Temporomandibular Joint
NCT05863286Cairo University28